BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33554683)

  • 1. Role of biomarkers CA-125, CA-15.3 and CA-19.9 in the distinction between endometriomas and ovarian neoplasms.
    Magalhães JS; Jammal MP; Crispim PCA; Murta EFC; Nomelini RS
    Biomarkers; 2021 May; 26(3):268-274. PubMed ID: 33554683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?
    Anastasi E; Manganaro L; Granato T; Benedetti Panici P; Frati L; Porpora MG
    Dis Markers; 2013; 35(5):331-5. PubMed ID: 24191126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas.
    Dai X; Jin C; Hu Y; Zhang Q; Yan X; Zhu F; Lin F
    Clin Chim Acta; 2015 Oct; 450():362-5. PubMed ID: 26403090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers and histopathologic features of ovarian endometriotic cysts.
    Selcuk S; Kucukbas M; Koc N; Cam C; Ozkaya E; Eser A; Karateke A
    J Obstet Gynaecol; 2021 Jul; 41(5):763-768. PubMed ID: 33054460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum follistatin levels in women with ovarian endometriosis.
    Florio P; Reis FM; Torres PB; Calonaci F; Abrao MS; Nascimento LL; Franchini M; Cianferoni L; Petraglia F
    Hum Reprod; 2009 Oct; 24(10):2600-6. PubMed ID: 19549703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Neutrophil-to-Lymphocyte Ratio Combined With CA-125 to Distinguish Endometriomas From Other Benign Ovarian Cysts.
    Tokmak A; Yildirim G; Öztaş E; Akar S; Erkenekli K; Gülşen P; Yilmaz N; Uğur M
    Reprod Sci; 2016 Jun; 23(6):795-802. PubMed ID: 26692541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis.
    Shin KH; Kim HH; Kwon BS; Suh DS; Joo JK; Kim KH
    Ann Lab Med; 2020 Jan; 40(1):40-47. PubMed ID: 31432638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rupture of an endometrioma with extremely high serum CA-125 level (> 10,000 IU/ml) and ascites resembling ovarian cancer.
    Park CM; Kim SY
    Eur J Gynaecol Oncol; 2014; 35(4):469-72. PubMed ID: 25118496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas.
    Crispim PCA; Jammal MP; Antão PKA; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
    Am J Reprod Immunol; 2020 Dec; 84(6):e13309. PubMed ID: 32698242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma urocortin levels in the diagnosis of ovarian endometriosis.
    Florio P; Reis FM; Torres PB; Calonaci F; Toti P; Bocchi C; Linton EA; Petraglia F
    Obstet Gynecol; 2007 Sep; 110(3):594-600. PubMed ID: 17766605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian damage due to cyst removal: a comparison of endometriomas and dermoid cysts.
    Perlman S; Kjer JJ
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):285-90. PubMed ID: 26669273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors.
    Landolfo C; Achten ETL; Ceusters J; Baert T; Froyman W; Heremans R; Vanderstichele A; Thirion G; Van Hoylandt A; Claes S; Oosterlynck J; Van Rompuy AS; Schols D; Billen J; Van Calster B; Bourne T; Van Gorp T; Vergote I; Timmerman D; Coosemans A
    Gynecol Oncol; 2020 Dec; 159(3):811-819. PubMed ID: 32994054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.
    Schutter EM; Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2002 Aug; 187(2):385-92. PubMed ID: 12193930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma.
    Mikami M; Tanabe K; Matsuo K; Miyazaki Y; Miyazawa M; Hayashi M; Asai S; Ikeda M; Shida M; Hirasawa T; Kojima N; Sho R; Iijima S
    Gynecol Oncol; 2015 Dec; 139(3):520-8. PubMed ID: 26477941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign or malignant ovarian neoplasms and ovarian endometriomas.
    Takahashi K; Kurioka H; Irikoma M; Ozaki T; Kanasaki H; Miyazaki K
    J Am Assoc Gynecol Laparosc; 2001 May; 8(2):278-84. PubMed ID: 11342738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel markers in the diagnostics of endometriomas: Urocortin, ghrelin, and leptin or leukocytes, fibrinogen, and CA-125?
    Chmaj-Wierzchowska K; Kampioni M; Wilczak M; Sajdak S; Opala T
    Taiwan J Obstet Gynecol; 2015 Apr; 54(2):126-30. PubMed ID: 25951715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between serum Ca-125 levels and surgical findings in women with symptoms evocative of endometriosis].
    Zomer MT; Ribeiro R; Trippia CH; Cavalcanti TC; Hayashi RM; Kondo W
    Rev Bras Ginecol Obstet; 2013 Jun; 35(6):262-7. PubMed ID: 23929199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transvaginal ultrasonography combined with color velocity imaging and pulsed Doppler in the diagnosis of endometrioma.
    Alcázar JL; Laparte C; Jurado M; López-García G
    Fertil Steril; 1997 Mar; 67(3):487-91. PubMed ID: 9091335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts.
    Ant Ö; Özakşit G; Güzel Aİ; Cavkaytar S; Kaba M; Topçu HO
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):236-9. PubMed ID: 26166333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.